BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 116966)

  • 1. Inhibition of human eosinophil chemotaxis by IgA paraproteins.
    Reed KJ; Van Epps DE; Williams RC
    Inflammation; 1979 Sep; 3(4):405-16. PubMed ID: 116966
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Suppression of leukocyte chemotaxis by human IgA myeloma components.
    Van Epps DE; Williams RC
    J Exp Med; 1976 Nov; 144(5):1227-42. PubMed ID: 825608
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of formylmethionyl-leucyl-phenylalanine-stimulated neutrophil chemiluminescence by human immunoglobulin A paraproteins.
    Van Epps DE; Brown SL
    Infect Immun; 1981 Dec; 34(3):864-70. PubMed ID: 7333672
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IgA paraprotein inhibition of human neutrophil chemotaxis. Reduced activity following treatment with IgA-specific protease from Neisseria gonorrhoeae.
    Van Epps DE; Plaut A; Bernier GM; Williams RC
    Inflammation; 1980 Jun; 4(2):137-44. PubMed ID: 6771212
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inactivation of polymorphonuclear-neutrophil derived eosinophil chemotactic factor by human serum.
    König W; Czarnetzki BM
    Int Arch Allergy Appl Immunol; 1978; 57(5):399-410. PubMed ID: 352966
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Suppression of human PMN bactericidal activity by human IgA paraproteins.
    Van Epps DE; Reed K; Williams RC
    Cell Immunol; 1978 Mar; 36(2):363-76. PubMed ID: 343924
    [No Abstract]   [Full Text] [Related]  

  • 7. Suppression of leucocyte chemokinesis and chemotaxis by human IgA.
    Kemp AS; Cripps AW; Brown S
    Clin Exp Immunol; 1980 May; 40(2):388-95. PubMed ID: 7438544
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Suppressive effect of IgA soluble immune complexes on neutrophil chemotaxis.
    Ito S; Mikawa H; Shinomiya K; Yoshida T
    Clin Exp Immunol; 1979 Sep; 37(3):436-40. PubMed ID: 116785
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Binding of immunoglobulin classes and subclasses to human neutrophils and eosinophils.
    Walsh GM; Kay AB
    Clin Exp Immunol; 1986 Feb; 63(2):466-72. PubMed ID: 3698341
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IgA-induced chemokinesis of human polymorphonuclear neutrophils: requirement of their Fc-alpha receptor.
    Sibille Y; Delacroix DL; Merill WW; Chatelain B; Vaerman JP
    Mol Immunol; 1987 Jun; 24(6):551-9. PubMed ID: 3657795
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of corticosteroids on eosinophil chemotaxis and adherence.
    Altman LC; Hill JS; Hairfield WM; Mullarkey MF
    J Clin Invest; 1981 Jan; 67(1):28-36. PubMed ID: 7005265
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhancement of eosinophil leukocyte chemotaxis by a factor in normal human serum (SEF).
    Czarnetzki BM
    Int Arch Allergy Appl Immunol; 1979; 60(3):315-24. PubMed ID: 489135
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Isotypic characterization of IgA paraproteins: association with other clinical and analytic data].
    González González JB; García Delgado R; Cámara Sáez E; Ortiz Maslloréns F
    Rev Clin Esp; 1996 Aug; 196(8):529-35. PubMed ID: 8984539
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selective inhibition of phosphodiesterase type IV suppresses the chemotactic responsiveness of rat eosinophils in vitro.
    Alves AC; Pires AL; Cruz HN; Serra MF; Diaz BL; Cordeiro RS; Lagente V; Martins MA
    Eur J Pharmacol; 1996 Sep; 312(1):89-96. PubMed ID: 8891583
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The release of eosinophil chemotactic activity and eosinophil chemokinesis inhibitory activity by mononuclear cells from atopic asthmatic and non-atopic subjects.
    Grzegorczyk J; Majkowska-Wojciechowska B; Kowalski ML
    Mediators Inflamm; 2000; 9(1):7-13. PubMed ID: 10877449
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunoglobulin A: Fc(alpha)RI interactions induce neutrophil migration through release of leukotriene B4.
    van der Steen L; Tuk CW; Bakema JE; Kooij G; Reijerkerk A; Vidarsson G; Bouma G; Kraal G; de Vries HE; Beelen RH; van Egmond M
    Gastroenterology; 2009 Dec; 137(6):2018-29.e1-3. PubMed ID: 19555692
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modulation of human neutrophil and eosinophil polymorphonuclear leukocyte chemotaxis: an analytical review.
    Valone FH
    Clin Immunol Immunopathol; 1980 Jan; 15(1):52-65. PubMed ID: 6987018
    [No Abstract]   [Full Text] [Related]  

  • 18. Spurious hyperphosphataemia caused by an IgA paraprotein: a topic revisited.
    Sinclair D; Smith H; Woodhead P
    Ann Clin Biochem; 2004 Mar; 41(Pt 2):119-24. PubMed ID: 15025801
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of neutrophil and eosinophil induced chemotaxis by nedocromil sodium and sodium cromoglycate.
    Bruijnzeel PL; Warringa RA; Kok PT; Kreukniet J
    Br J Pharmacol; 1990 Apr; 99(4):798-802. PubMed ID: 2163279
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum inhibitor of C5 fragment-mediated polymorphonuclear leukocyte chemotaxis associated with chronic hemodialysis.
    Goldblum SE; Van Epps DE; Reed WP
    J Clin Invest; 1979 Jul; 64(1):255-64. PubMed ID: 447856
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.